#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Gaucher's disease type I Factor IX deficiency Glycogen storage disease type II Essential thrombocythaemia Mantle cell lymphoma stage III Neoplasm Marfan's syndrome Infantile apnoea Malignant peritoneal neoplasm Dementia with Lewy bodies Ocular myasthenia Activated PI3 kinase delta syndrome Retinopathy of prematurity T-cell lymphoma Glioma More trials…

    Learn about Rare Diseases

    Familial haemophagocytic lymphohistiocytosis – Diagnostics Basal cell naevus syndrome – Basic Information Krabbe’s disease – Basic Information Mantle cell lymphoma refractory – Diagnostics Lysosomal storage disorder – Basic Information Alport’s syndrome – Diagnostics Thrombotic thrombocytopenic purpura – Life with Disease Hereditary angioedema with C1 esterase inhibitor deficiency – Diagnostics Haemophagocytic lymphohistiocytosis Osteosarcoma recurrent – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Enoxaparin Sodium Lolium Perenne TALADEGIB Fexofenadine Azilsartan Medoxomil Corticosteroids, Plain Fezolinetant Dipyridamole Mps-103 Isoprenaline Hydrochloride Eltrombopag Revumenib Afatinib Erythromycin Minocycline Hydrochloride Perflutren Melphalan Flufenamide LTI-03 Interleukin-1 Sufentanil More therapies…

    Learn about Your Condition

    Lip and/or oral cavity cancer Synovial sarcoma metastatic Hypoaesthesia Nephrogenic anaemia Dry eye Congenital aplastic anaemia Thyroid mass Adenocarcinoma pancreas Scoliosis Osteomyelitis Magnetic resonance imaging Breast cancer ROHHAD syndrome Anal cancer recurrent Arterial tortuosity syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Azienda Sanitaria Universitaria Giuliano Isontina

Azienda Sanitaria Universitaria Giuliano Isontina

Strada Di Fiume 447, Trieste, 34149, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Safety, Tolerability, and Preliminary Efficacy of Soquelitinib in Adults with Moderate to Severe Atopic Dermatitis (Phase 2 Study)

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Dermatitis atopic
    Bulgaria Czechia Germany Italy Poland Spain

  • Efficacy and safety of eplontersen sodium plus ALXN2220 in adults with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM)

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Cardiac amyloidosis
    Investigated Drugs:
    • Alxn2220
    France Germany Italy Spain Sweden

  • Phase II Study of Cemiplimab to Spare Surgery in Patients with Locally Advanced Cutaneous Squamous Cell Carcinoma

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of skin
    Investigated Drugs:
    • Cemiplimab
    Italy

  • Study of Nebulized Human Normal Immunoglobulin (CSL787) for Adults with Non-cystic Fibrosis Bronchiectasis to Find Best Dose and Test Safety

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Bronchiectasis
    Investigated Drugs:
    • Human Normal Immunoglobulin
    Belgium Denmark France Germany Greece Hungary +4

  • Study on the Effectiveness of Tezepelumab for Adults with Eosinophilic Granulomatosis with Polyangiitis (EGPA)

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Eosinophilic granulomatosis with polyangiitis
    Investigated Drugs:
    • Tezepelumab
    • Placebo
    Italy

  • Study on the Safety of Argon and Oxygen Ventilation for Patients Resuscitated from Cardiac Arrest

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Cardiac arrest
    Investigated Drugs:
    • Argon
    • Nitrous Oxide
    • Oxygen
    Italy

  • Study Comparing R-MINI-CHOP and R-MINI-CHP with Polatuzumab Vedotin for Treating Diffuse Large B-Cell Lymphoma in Patients Aged 80 and Older or Frail Patients Aged 75 and Older

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma refractory
    Investigated Drugs:
    • Polatuzumab Vedotin
    • Cyclophosphamide
    • Doxorubicin Hydrochloride
    Denmark Estonia Finland Italy Norway Sweden

  • Study on Colchicine for Treating Patients with Inflammatory Cardiomyopathy

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Cardiomyopathy
    Investigated Drugs:
    • Colchicine
    Italy

  • Study of ianalumab for adults with primary immune thrombocytopenia or warm-antibody autoimmune hemolytic anemia who previously responded to ianalumab

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Immune thrombocytopenia
    • Warm autoimmune haemolytic anaemia
    Investigated Drugs:
    • Danazol
    • Entecavir
    • Ianalumab
    Belgium Bulgaria Czechia France Germany Hungary +3

  • A Study of Ianalumab and Eltrombopag for Patients with Primary Immune Thrombocytopenia Who Did Not Respond Well to or Relapsed After Steroid Treatment

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Immune thrombocytopenia
    Investigated Drugs:
    • Eltrombopag
    • H2-Receptor Antagonists
    • Entecavir
    Austria Belgium Czechia France Germany Hungary +5
Previous Page
1 … 4 5 6 7 8 9
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!